Anlotinib Hydrochloride Combined With Epirubicin and Ifosfamide for Soft Tissue Sarcoma Patients

NCT03815474 · clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
47
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Liaoning Cancer Hospital & Institute

Collaborators